ICU MEDICAL INC/DE
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.2B | $2.4B | $2.3B | $2.3B | $1.3B |
| Cost of revenue | $1.4B | $1.6B | $1.5B | $1.6B | $824.8M |
| Gross profit | $822.0M | $824.8M | $739.9M | $697.8M | $491.5M |
| Selling, general & administrative | $625.2M | $638.8M | $606.7M | $608.3M | $302.6M |
| Research and development | $87.5M | $88.6M | $85.3M | $93.0M | $47.5M |
| Operating expenses | $779.2M | $781.8M | $717.0M | $740.7M | $368.2M |
| Operating income | $42.8M | $43.0M | $22.8M | -$42.9M | $123.2M |
| Interest expense | $93.3M | $106.5M | $102.7M | $70.8M | $858,000 |
| Pretax income | $4.4M | -$66.0M | -$78.3M | — | — |
| Income tax expense | $2.4M | $51.7M | -$48.6M | -$40.1M | $20.1M |
| Net income | $732,000 | -$117.7M | -$29.7M | -$74.3M | $103.1M |
| Balance Sheet | |||||
| Cash and equivalents | — | — | — | $208.8M | $552.8M |
| Current assets | $1.2B | $1.4B | $1.2B | $1.2B | $1.0B |
| Total assets | $4.1B | $4.2B | $4.4B | $4.5B | $1.9B |
| Current liabilities | $498.9M | $556.2M | $481.8M | $494.6M | $200.8M |
| Total debt | $1.3B | $1.6B | $1.6B | $1.7B | — |
| Stockholders' equity | $2.1B | $2.0B | $2.1B | $2.1B | $1.6B |
| Cash Flow Statement | |||||
| Cash from operations | $179.8M | $204.0M | $166.2M | -$62.1M | $267.5M |
| Depreciation and amortization | $200.7M | $219.5M | $228.8M | $235.2M | $89.7M |
| Stock-based compensation | $55.8M | $46.9M | $40.6M | $36.0M | $27.3M |
| Capital expenditure | $88.0M | $79.4M | $83.9M | $90.3M | $68.5M |
| Free cash flow | $91.8M | $124.7M | $82.3M | -$152.4M | $199.0M |
| Share repurchases | $8.8M | $12.0M | $9.3M | $10.9M | $8.3M |
Shares outstanding 25.0M · Free float 81.3%
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.